News

The FDA has cleared the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio test, the first blood test for early Alzheimer's ...
The newly approved test, developed by Fujirebio Diagnostics, Inc., is designed for patients aged 55 and older who are ...
The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment ...
The action establishes belzutifan as the only approved oral therapy for PPGL. The approval stipulates use in adults and children 12 years or older with locally advanced, unresectable, or metastatic ...
Newer medications, such as Mounjaro and Wegovy, exhibit both more total weight lost and faster weight regain than older ...